These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21167373)

  • 1. Readers' responses to "Cancer of unknown primary site: advances in diagnostics".
    Emmons R; Morris GJ
    Semin Oncol; 2010 Dec; 37(6):555. PubMed ID: 21167373
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of gene expression profiling and mutation analysis increases the cost of care for patients with carcinoma of unknown primary; does it also improve survival?
    Prasad V; Oseran A; Fakhrejahani F
    Eur J Cancer; 2016 Feb; 54():159-162. PubMed ID: 26608119
    [No Abstract]   [Full Text] [Related]  

  • 3. Microarray analysis as a helpful tool in identifying the primary tumour in cancer with an unknown primary site.
    Soesan M; de Snoo F; Westerga J; Floore A; Bender R
    Neth J Med; 2010 Jan; 68(1):50-1. PubMed ID: 20103826
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular classification of unknown primary cancer.
    Bender RA; Erlander MG
    Semin Oncol; 2009 Feb; 36(1):38-43. PubMed ID: 19179186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Real-time quantification of microRNAs in Huh7 cells by stem-loop reverse transcriptase polymerase chain reaction].
    Gong BD; Xie Q; Wang L; Xiang XG; Lin LY; Zhao GD; Wang H; Yu H
    Zhonghua Gan Zang Bing Za Zhi; 2009 Aug; 17(8):603-6. PubMed ID: 19719919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin.
    Tothill RW; Kowalczyk A; Rischin D; Bousioutas A; Haviv I; van Laar RK; Waring PM; Zalcberg J; Ward R; Biankin AV; Sutherland RL; Henshall SM; Fong K; Pollack JR; Bowtell DD; Holloway AJ
    Cancer Res; 2005 May; 65(10):4031-40. PubMed ID: 15899792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small RNAs are raising big expectations.
    Hede K
    J Natl Cancer Inst; 2009 Jun; 101(12):840-1. PubMed ID: 19509361
    [No Abstract]   [Full Text] [Related]  

  • 8. Unknown primary tumors.
    Natoli C; Ramazzotti V; Nappi O; Giacomini P; Palmeri S; Salvatore M; Landriscina M; Zilli M; Natali PG; Tinari N; Iacobelli S
    Biochim Biophys Acta; 2011 Aug; 1816(1):13-24. PubMed ID: 21371531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of biological markers in the diagnosis of cancers of unknown primary tumor.
    Ruddon RW; Norton SE
    Semin Oncol; 1993 Jun; 20(3):251-60. PubMed ID: 8503021
    [No Abstract]   [Full Text] [Related]  

  • 10. Cancer of unknown primary origin: using ancillary techniques with caution.
    Bhargava R; Dabbs DJ
    J Clin Oncol; 2013 Apr; 31(11):1478-9. PubMed ID: 23439751
    [No Abstract]   [Full Text] [Related]  

  • 11. Absolute quantitation of microRNAs with a PCR-based assay.
    Duncan DD; Eshoo M; Esau C; Freier SM; Lollo BA
    Anal Biochem; 2006 Dec; 359(2):268-70. PubMed ID: 17007808
    [No Abstract]   [Full Text] [Related]  

  • 12. Head and neck cancer with an occult primary tumor.
    Jacobs CD; Pinto HA
    N Engl J Med; 1992 Jan; 326(1):58-9. PubMed ID: 1309197
    [No Abstract]   [Full Text] [Related]  

  • 13. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
    Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y
    Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A focused approach to patients with cancer of unknown primary site.
    Meyers FJ; Lewis JP
    West J Med; 1986 Sep; 145(3):403-4. PubMed ID: 3765625
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cancer of unknown primary site-current status and future direction].
    Ichikawa Y; Okamoto I; Nakagawa K
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):907-9. PubMed ID: 19542709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic analysis in the diagnosis of neoplasms of unknown primary tumor site.
    Ilson DH; Motzer RJ; Rodriguez E; Chaganti RS; Bosl GJ
    Semin Oncol; 1993 Jun; 20(3):229-37. PubMed ID: 8503018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum tumor markers in the diagnosis of cancer of unknown primary site].
    Cohen AD; Neuman A; Cohen Y
    Harefuah; 1995 Oct; 129(7-8):279-82. PubMed ID: 8549972
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of occult CNS involvement of follicular small cleaved lymphoma by the polymerase chain reaction.
    Shibata D; Nichols P; Sherrod A; Rabinowitz A; Bernstein-Singer L; Hu E
    Mod Pathol; 1990 Jan; 3(1):71-5. PubMed ID: 2308923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-21 microRNA expression in human gastric carcinomas and its clinical association.
    Chan SH; Wu CW; Li AF; Chi CW; Lin WC
    Anticancer Res; 2008; 28(2A):907-11. PubMed ID: 18507035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma.
    Guo Y; Chen Z; Zhang L; Zhou F; Shi S; Feng X; Li B; Meng X; Ma X; Luo M; Shao K; Li N; Qiu B; Mitchelson K; Cheng J; He J
    Cancer Res; 2008 Jan; 68(1):26-33. PubMed ID: 18172293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.